Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,264 | -91,941 | -67,198 | -51,262 | -22,575 |
| Depreciation Amortization | 903 | 3,447 | 2,426 | 1,408 | 638 |
| Accounts receivable | -1,055 | N/A | N/A | N/A | -137 |
| Accounts payable and accrued liabilities | 257 | 2,498 | 2,328 | 2,402 | 3,416 |
| Other Working Capital | -5,190 | 3,408 | -3,318 | -2,508 | -1,922 |
| Other Operating Activity | 3,201 | 16,881 | 12,074 | 9,390 | -3,620 |
| Operating Cash Flow | $-21,148 | $-65,708 | $-53,687 | $-40,570 | $-24,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,000 | 26,091 | 19,411 | 12,151 | 3,055 |
| PPE Investments | -407 | -1,970 | -1,135 | -852 | -554 |
| Net Acquisitions | N/A | -10,000 | -10,000 | -7,000 | -7,000 |
| Investing Cash Flow | $2,593 | $14,121 | $8,276 | $4,299 | $-4,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -214 | N/A | N/A | N/A |
| Debt Repayment | -54 | N/A | -160 | -107 | -103 |
| Common Stock Issued | N/A | 505 | 314 | 314 | 284 |
| Other Financing Activity | -441 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-495 | $291 | $154 | $207 | $180 |
| Beginning Cash Position | 81,214 | 132,511 | 132,511 | 132,511 | 132,511 |
| End Cash Position | 62,165 | 81,214 | 87,253 | 96,447 | 103,991 |
| Net Cash Flow | $-19,049 | $-51,296 | $-45,258 | $-36,063 | $-28,519 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,148 | -65,708 | -53,687 | -40,570 | -24,200 |
| Capital Expenditure | -407 | -1,971 | -1,136 | -852 | -555 |
| Free Cash Flow | -21,555 | -67,678 | -54,823 | -41,422 | -24,755 |